Indication
Severe combined immunodeficiency disease
Severe combined immunodeficiency disease is a rare, life-threatening primary immunodeficiency disorder characterized by profound defects in cellular and humoral immunity. Read more about Severe combined immunodeficiency disease
45 drugs 17 manufacturers
Drugs that treat it
Common Severe combined immunodeficiency disease therapies.
GAMMAGARD LIQUID (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
GAMMAGARD S-D (immune globulin,gamm(IgG)/glycine/glucose/IgA 0 to 50 mcg/mL)
HYQVIA (immune globulin,gamma(IgG) human/hyaluronidase, human recomb)
HYQVIA IG COMPONENT (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
GAMMAGARD LIQUID (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
GAMMAGARD S-D (immune globulin,gamm(IgG)/glycine/glucose/IgA 0 to 50 mcg/mL)
HYQVIA (immune globulin,gamma(IgG) human/hyaluronidase, human recomb)
HYQVIA IG COMPONENT (immune globulin,gamm(IgG)/glycine/IgA greater than 50 mcg/mL)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSevere combined immunodeficiency disease is a rare, life-threatening primary immunodeficiency disorder characterized by profound defects in cellular and humoral immunity.
Primarily manifesting during early infancy, it affects the immune system due to diverse monogenic mutations that severely disrupt T-lymphocyte differentiation and development, often accompanied by absent or nonfunctional B lymphocytes and natural killer cells.
Pathophysiologically, the resulting inability to mount an adaptive immune response leaves infants vulnerable to recurrent, severe, and opportunistic bacterial, viral, and fungal infections, chronic diarrhea, and failure to thrive.
Without timely intervention to restore immune function, this condition typically leads to fatal complications within the first to second year of life.
- nih.gov
Severe combined immunodeficiency disease is a rare, life-threatening primary immunodeficiency disorder characterized by profound defects in cellular and humoral immunity Pathophysiologically, the resulting inability to mount an adaptive immune response leaves infants vulnerable to recurrent, severe, and opportunistic bacterial, viral, and fungal infections, chronic diarrhea, and failure to thrive Without timely intervention to restore immune function, this condition typically leads to fatal comp...
- nih.gov
Severe combined immunodeficiency disease is a rare, life-threatening primary immunodeficiency disorder characterized by profound defects in cellular and humoral immunity Primarily manifesting during early infancy, it affects the immune system due to diverse monogenic mutations that severely disrupt T-lymphocyte differentiation and development, often accompanied by absent or nonfunctional B lymphocytes and natural killer cells Pathophysiologically, the resulting inability to mount an adaptive imm...
- medlineplus.gov
Severe combined immunodeficiency disease is a rare, life-threatening primary immunodeficiency disorder characterized by profound defects in cellular and humoral immunity Without timely intervention to restore immune function, this condition typically leads to fatal complications within the first to second year of life
- nih.gov
Primarily manifesting during early infancy, it affects the immune system due to diverse monogenic mutations that severely disrupt T-lymphocyte differentiation and development, often accompanied by absent or nonfunctional B lymphocytes and natural killer cells Pathophysiologically, the resulting inability to mount an adaptive immune response leaves infants vulnerable to recurrent, severe, and opportunistic bacterial, viral, and fungal infections, chronic diarrhea, and failure to thrive
- hrsa.gov
Primarily manifesting during early infancy, it affects the immune system due to diverse monogenic mutations that severely disrupt T-lymphocyte differentiation and development, often accompanied by absent or nonfunctional B lymphocytes and natural killer cells
- medlineplus.gov
Pathophysiologically, the resulting inability to mount an adaptive immune response leaves infants vulnerable to recurrent, severe, and opportunistic bacterial, viral, and fungal infections, chronic diarrhea, and failure to thrive
Personalize your experience
Follow Severe combined immunodeficiency disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.